Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C21H26N2O4 |
Molecular Weight | 370.4421 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC=C(C=C1OC)[C@H](O)CN2CCN(CC2)C3=CC=CC=CC3=O
InChI
InChIKey=SGEKLKJQLHJVDK-LJQANCHMSA-N
InChI=1S/C21H26N2O4/c1-26-20-9-8-16(14-21(20)27-2)19(25)15-22-10-12-23(13-11-22)17-6-4-3-5-7-18(17)24/h3-9,14,19,25H,10-13,15H2,1-2H3/t19-/m1/s1
Molecular Formula | C21H26N2O4 |
Molecular Weight | 370.4421 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Ciladopa, is a troponylpiperazine derivative and dopamine agonist that has been shown to influence dopaminergic mechanisms in animals. Preclinical pharmacological studies have suggested that it has antiparkinsonian activity similar to that of bromocriptine but without many of the troublesome side effects. Unfortunately in some clinical trials no significant differences was found among the treatment groups and placebo.
CNS Activity
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: P14416 Gene ID: 1813.0 Gene Symbol: DRD2 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/3774130 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/3606037
15 mg twice daily for 8 weeks
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:13:38 GMT 2023
by
admin
on
Fri Dec 15 16:13:38 GMT 2023
|
Record UNII |
D09L486R3J
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C66884
Created by
admin on Fri Dec 15 16:13:38 GMT 2023 , Edited by admin on Fri Dec 15 16:13:38 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C045964
Created by
admin on Fri Dec 15 16:13:38 GMT 2023 , Edited by admin on Fri Dec 15 16:13:38 GMT 2023
|
PRIMARY | |||
|
SUB06262MIG
Created by
admin on Fri Dec 15 16:13:38 GMT 2023 , Edited by admin on Fri Dec 15 16:13:38 GMT 2023
|
PRIMARY | |||
|
DTXSID101024642
Created by
admin on Fri Dec 15 16:13:38 GMT 2023 , Edited by admin on Fri Dec 15 16:13:38 GMT 2023
|
PRIMARY | |||
|
Ciladopa
Created by
admin on Fri Dec 15 16:13:38 GMT 2023 , Edited by admin on Fri Dec 15 16:13:38 GMT 2023
|
PRIMARY | |||
|
D09L486R3J
Created by
admin on Fri Dec 15 16:13:38 GMT 2023 , Edited by admin on Fri Dec 15 16:13:38 GMT 2023
|
PRIMARY | |||
|
CHEMBL2110793
Created by
admin on Fri Dec 15 16:13:38 GMT 2023 , Edited by admin on Fri Dec 15 16:13:38 GMT 2023
|
PRIMARY | |||
|
C79568
Created by
admin on Fri Dec 15 16:13:38 GMT 2023 , Edited by admin on Fri Dec 15 16:13:38 GMT 2023
|
PRIMARY | |||
|
5559
Created by
admin on Fri Dec 15 16:13:38 GMT 2023 , Edited by admin on Fri Dec 15 16:13:38 GMT 2023
|
PRIMARY | |||
|
100000081291
Created by
admin on Fri Dec 15 16:13:38 GMT 2023 , Edited by admin on Fri Dec 15 16:13:38 GMT 2023
|
PRIMARY | |||
|
133371
Created by
admin on Fri Dec 15 16:13:38 GMT 2023 , Edited by admin on Fri Dec 15 16:13:38 GMT 2023
|
PRIMARY | |||
|
80109-27-9
Created by
admin on Fri Dec 15 16:13:38 GMT 2023 , Edited by admin on Fri Dec 15 16:13:38 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |